These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11846857)

  • 1. Absence of a pharmacokinetic interaction between digoxin and levofloxacin.
    Chien SC; Rogge MC; Williams RR; Natarajan J; Wong F; Chow AT
    J Clin Pharm Ther; 2002 Feb; 27(1):7-12. PubMed ID: 11846857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic interaction of sparfloxacin and digoxin.
    Johnson RD; Dorr MB; Hunt TL; Conway S; Talbot GH
    Clin Ther; 1999 Feb; 21(2):368-79. PubMed ID: 10211539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical pharmacokinetics of levofloxacin.
    Fish DN; Chow AT
    Clin Pharmacokinet; 1997 Feb; 32(2):101-19. PubMed ID: 9068926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levofloxacin does not alter cyclosporine disposition.
    Doose DR; Walker SA; Chien SC; Williams RR; Nayak RK
    J Clin Pharmacol; 1998 Jan; 38(1):90-3. PubMed ID: 9597565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of an effect of levofloxacin on warfarin pharmacokinetics and anticoagulation in male volunteers.
    Liao S; Palmer M; Fowler C; Nayak RK
    J Clin Pharmacol; 1996 Nov; 36(11):1072-7. PubMed ID: 8973996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses.
    Chien SC; Rogge MC; Gisclon LG; Curtin C; Wong F; Natarajan J; Williams RR; Fowler CL; Cheung WK; Chow AT
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2256-60. PubMed ID: 9333057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and safety of oral levofloxacin in human immunodeficiency virus-infected individuals receiving concomitant zidovudine.
    Chien SC; Chow AT; Rogge MC; Williams RR; Hendrix CW
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1765-9. PubMed ID: 9257757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind evaluation of the safety and pharmacokinetics of multiple oral once-daily 750-milligram and 1-gram doses of levofloxacin in healthy volunteers.
    Chien SC; Wong FA; Fowler CL; Callery-D'Amico SV; Williams RR; Nayak R; Chow AT
    Antimicrob Agents Chemother; 1998 Apr; 42(4):885-8. PubMed ID: 9559801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of food and sucralfate on a single oral dose of 500 milligrams of levofloxacin in healthy subjects.
    Lee LJ; Hafkin B; Lee ID; Hoh J; Dix R
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2196-200. PubMed ID: 9333047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cilomilast: pharmacokinetic and pharmacodynamic interactions with digoxin.
    Zussman BD; Kelly J; Murdoch RD; Clark DJ; Mbchb ; Schubert C; Collie H
    Clin Ther; 2001 Jun; 23(6):921-31. PubMed ID: 11440291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of pharmacokinetic interaction between gemifloxacin and digoxin in healthy elderly volunteers.
    Vousden M; Allen A; Lewis A; Ehren N
    Chemotherapy; 1999; 45(6):485-90. PubMed ID: 10567779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of interaction between levofloxacin and oxycodone: pharmacokinetics and drug disposition.
    Grant EM; Zhong M; Fitzgerald JF; Nicolau DP; Nightingale C; Quintiliani R
    J Clin Pharmacol; 2001 Feb; 41(2):206-9. PubMed ID: 11210403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and safety of high-dose and extended-interval regimens of levofloxacin in human immunodeficiency virus-infected patients.
    Piscitelli SC; Spooner K; Baird B; Chow AT; Fowler CL; Williams RR; Natarajan J; Masur H; Walker RE
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2323-7. PubMed ID: 10471591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic Interactions Between Mirabegron and Metformin, Warfarin, Digoxin or Combined Oral Contraceptives.
    Groen-Wijnberg M; van Dijk J; Krauwinkel W; Kerbusch V; Meijer J; Tretter R; Zhang W; van Gelderen M
    Eur J Drug Metab Pharmacokinet; 2017 Jun; 42(3):417-429. PubMed ID: 27350625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of lacosamide on the steady-state pharmacokinetics of digoxin: results from a phase I, multiple-dose, double-blind, randomised, placebo-controlled, crossover trial.
    Cawello W; Mueller-Voessing C; Andreas JO
    Clin Drug Investig; 2014 May; 34(5):327-34. PubMed ID: 24634110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin-clarithromycin interaction.
    Rengelshausen J; Göggelmann C; Burhenne J; Riedel KD; Ludwig J; Weiss J; Mikus G; Walter-Sack I; Haefeli WE
    Br J Clin Pharmacol; 2003 Jul; 56(1):32-8. PubMed ID: 12848773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple doses of the antimuscarinic agent solifenacin do not affect the pharmacodynamics or pharmacokinetics of warfarin or the steady-state pharmacokinetics of digoxin in healthy subjects.
    Smulders RA; Kuipers ME; Krauwinkel WJ
    Br J Clin Pharmacol; 2006 Aug; 62(2):210-7. PubMed ID: 16842396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability of two oral formulations of a single dose of levofloxacin 500 mg: an open-label, randomized, two-period crossover comparison in healthy Mexican volunteers.
    Galan-Herrera JF; Poo JL; Rosales-Sanchez O; Fuentes-Fuentes E; Cariño L; Burke-Fraga V; Namur S; Parra MG
    Clin Ther; 2009 Aug; 31(8):1796-803. PubMed ID: 19808138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of rofecoxib on the pharmacokinetics of digoxin in healthy volunteers.
    Schwartz JI; De Smet M; Larson PJ; Verbesselt R; Ebel DL; Lins R; Lens S; Porras AG; Gertz BJ
    J Clin Pharmacol; 2001 Jan; 41(1):107-12. PubMed ID: 11144988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of interaction between pantoprazole and digoxin at therapeutic doses in man.
    Hartmann M; Huber R; Bliesath H; Steinijans VW; Koch HJ; Wurst W; Kunz K
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S67-71. PubMed ID: 8793605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.